
Accelerated Production Process
Streamlined workflows to ensure efficient scale-up and reduce time-to-market.

Life sciences is a broad scientific field of study focused on living organisms, biological processes, and the development of products and technologies that improve human health and well-being. It stretches the entire spectrum of discovery, development, production, and analysis of biological and chemical materials used across the healthcare and pharmaceutical value chain.
At Scimplify, we organise our life sciences offering across three key verticals: Pharmaceuticals, Biologics, and Life Sciences R&D and excels in pharmaceutical ingredients, Intermediates, APIs, Excipients, Biologics-related materials, Fermentation-Derived Products, and Specialty Chemicals for research, development, formulation, and manufacturing.
From early-stage research and preclinical development to formulation and commercial manufacturing, Scimplify connects life sciences organizations with specialised chemical and biological materials aligned with their technical and supply requirements.
Typical first response within 24 hours.
Global pharmaceutical landscape is experiencing a structural shift toward supply chain resilience. Modern innovators are rapidly transitioning away from fragmented, volatile merchant brokers toward deeply integrated development models that mitigate geopolitical instability, sudden regulatory actions, and core material shortages. Operating across 25+ consumer countries, including the United Kingdom, Japan, Italy, Spain, and South Korea – Scimplify connects this market gap. We act as an end-to-end partner by running a manufacturing network composed of 75+ GMP-audited facilities and 3 in-house R&D centres. This scale ensures our global life sciences partners benefit from diversified, backward-integrated supply chains that protect downstream commercial interests from any market disruption and coordinate the ever-evolving pharmaceutical advances.

Streamlined workflows to ensure efficient scale-up and reduce time-to-market.

Delivering high-quality manufacturing solutions to ensure your product is ready for commercial success.

Supporting all stages of manufacturing, from initial pilot production to full-scale commercial production.
100% guarantee on the quality of chemicals with a robust 3-step quality inspection process
Capabilities for producing APIs and Intermediates in controlled quantities tailored to your needs.
Cutting-edge research and development to improve process efficiency during manufacturing
Built on science, quality and trust
75+ GMP sites
Multi-nuclear NMR & HPCL
Regulatory ready Dossiers
Scimplify's platform utilises an advanced, asset-light manufacturing aggregation model. By combining internal process optimisation specialists with thoroughly vetted, Tier-1 contract manufacturing sites, we eliminate the capacity constraints typical of standalone legacy providers. For commercial procurement teams and technical directors, this structure delivers cost efficiency alongside rapid operational scaling.
APIs, Intermediates, Pellets, Formulations, Key Starting Materials & Excipients
R&D, CDMO, Generics and NCEs
CDMO & Regulatory Support
Full-Spectrum Pharma Manufacturing & Sourcing
Trusted API Exporter India, delivering high-quality Ferric Carboxymaltose and pharmaceutical APIs to 10+ countries
Scimplify's network runs complex organic reactions safely across a broad range of temperatures and pressures - from milligrams in the lab to hundreds of tonnes a month on the plant floor.
MTM COMBINED INSTALLED CAPACITY
Scientists
In-house R&D labs
PhDs
Core chemistries
Patents
Molecules developed (Japan, USA, Taiwan, China, India)
Molecules evaluated in CDMO
A curated selection of our APIs, intermediates, and pellets manufactured across regulated and emerging markets.
Active Pharmaceutical Ingredients (APIs) Master Portfolio
| Product Name | Pharmacopeia Status | Therapeutic Category |
|---|---|---|
| Folic Acid | IP / USP | Vitamin B9 / Nutraceutical |
| Itraconazole | IP / USP / BP | Anti-Fungal Active |
| Rabeprazole Sodium | IP / USP | Gastrointestinal / GERD Care |
| Omeprazole | IP / USP | Gastrointestinal / GERD Care |
| Apremilast | USP | Anti-Inflammatory / PDE4 Inhibitor |
| Clopidogrel Bisulfate | IP / USP | Anti-Platelet / Cardiovascular |
| Orlistat | IH / USP | Anti-Obesity / Lipase Inhibitor |
| Tacrolimus | IP / USP / BP / EP | Immunosuppressant |
| Aceclofenac | IP / USP | NSAID / Pain Management |
| Valsartan | IP / USP / BP | Anti-Hypertensive / Cardiovascular |
| Losartan Potassium | IP / USP / BP | Anti-Hypertensive / Cardiovascular |
| Faropenem | JP | Penem Antibiotic / Anti-Infective |
| Deflazacort | IH | Corticosteroid / Anti-Inflammatory |
| Hydrocortisone Acetate | IP / USP | Corticosteroid / Anti-Inflammatory |
| Clobetasone Propionate | IP / USP / BP / Ph.Eur | Topical Corticosteroid / Dermatology |
| Levosulpiride | IP | Antipsychotic / Prokinetic |
| Montelukast | IP / USP | Anti-Asthmatic / Leukotriene Antagonist |
From our hub in India, Scimplify connects a live network of manufacturing, sourcing, and regulatory partners spanning every major pharmaceutical market worldwide.

APIs, Intermediates, Excipients & KSMs, Pellets & Formulations under one roof

Lab to commercial execution with QC & documentation

Regulatory-ready dossiers & global compliance support

75+ GMP-audited sites for flexible manufacturing

Cross-border sourcing, logistics & regulatory support

Licensing, co-development & strategic supply partnerships
From lab-scale testing to pilot-scale production to finished formulations and regulatory support, our CRO services are designed to streamline your journey to market with precision and expertise.
From lab-scale testing to pilot-scale production to finished formulations and regulatory support, our CRO services are designed to streamline your journey to market with precision and expertise.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : 3-Isopropoxyaniline (CAS No: 41406-00-2), commercially referred to as 3-IPA or m-isopropoxyaniline, is undergoing a significant transition from a conventional speciality chemical to a vital, high-performance agrochemical and pharmaceutical intermediate across the global crop protection, life science, and speciality dye industries. Featuring a reactive primary aromatic amine coupled with an ether-linked isopropyl group, 3-isopropoxyaniline is a cornerstone of the international organic synthesis supply chain, driving the global manufacturing of major carbamate fungicides (such as Iprovalicarb), technical-grade insecticides, and targeted pharmaceutical building blocks. Beyond standard crop protection roles, its robust chemical profile makes it highly valuable in cross-border fine chemical synthesis, functioning as a critical building block for modern life-saving therapeutics, specialised colour developers, and high-performance industrial intermediates. This versatility reflects a global sourcing shift toward validated, high-purity liquid/solid variants to guarantee predictable reaction kinetics, low oxidative degradation, and consistent material performance worldwide. As a globally established 3-Isopropoxyaniline supplier, we ensure dependable bulk supply, strict quality control, and complete technical dossiers, including 3-Isopropoxyaniline CoA and 3-IPA (3-isopropoxyaniline) TDS across all industrial and technical grades. Beyond supply, we support our international partners through the entire product lifecycle from pilot-scale chemical optimisation to full commercial manufacturing, ensuring robust quality assurance, global regulatory alignment, and secure cross-border supply chain and logistics coordination.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : 2,6-Difluorobenzamide (CAS No: 18063-03-1) is undergoing a significant transition from a niche aromatic intermediate to a high-volume, core agrochemical and pharmaceutical precursor across the global crop protection and advanced life science markets, where its dual-ortho fluorinated benzamide architecture is leveraged in large-scale commercial active ingredient synthesis. Serving as a fundamental fluorinated primary amide building block, 2,6-Difluorobenzamide is a cornerstone of the international fine chemical supply chain, driving the global manufacturing of major benzoylurea chitin synthesis inhibitors such as Diflubenzuron, Lufenuron, Hexaflumuron, and Teflubenzuron, alongside high-value therapeutic blockbusters like the antiretroviral API Dolutegravir. Beyond standard chemical intermediate roles, its exceptionally stable fluorinated ring profile makes it indispensable in cross-border pharmaceuticals, advanced veterinary insecticides, and high-performance agrochemical synthesis. This versatility reflects a global sourcing shift toward strictly validated, high-purity solid crystalline variants to ensure predictable reaction yields, low elemental impurities, and reproducible condensation kinetics worldwide. As a globally established 2,6-Difluorobenzamide supplier, we ensure dependable bulk supply, strict quality control, and complete technical dossiers, including 2,6-Difluorobenzamide CoA and TDS across all industrial and technical grades. Beyond supply, we support our international partners through the entire product lifecycle from pilot-scale process optimization to full commercial manufacturing, ensuring robust quality assurance, global regulatory alignment, and secure cross-border supply chain and logistics coordination.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : 3-Fluorophenol (CAS No: 372-20-3), also known as m-fluorophenol, is undergoing a significant transition from a standard specialty reagent to a vital, high-performance polymer, liquid crystal, and agrochemical intermediate in the global crop protection, pharmaceutical synthesis, and advanced material science markets, where its exceptional fluorinated reactivity and customizable molecular design are leveraged across diverse megaproject and bulk synthesis applications. Serving as a fundamental monofluorinated phenolic core, 3-Fluorophenol is a cornerstone of the international organic synthesis supply chain, supporting the global manufacturing of high-potency agrochemical active ingredients, technical-grade fungicides, and critical pharmaceutical building blocks. Beyond standard chemical intermediate roles, its robust chemical profile makes it highly valuable in cross-border pharmaceuticals and fine chemical synthesis, functioning as a critical building block for modern life-saving therapeutics, active liquid crystal displays (LCDs), and specialised industrial intermediates. This versatility reflects a global sourcing shift toward validated, high-purity liquid variants to guarantee predictable reaction kinetics and consistent material performance worldwide. As a globally established 3-Fluorophenol supplier, we ensure dependable bulk supply, strict quality control, and complete technical dossiers, including 3-Fluorophenol CoA and TDS across all industrial and technical grades. Beyond supply, we support our international partners through the entire product lifecycle from pilot-scale chemical optimisation to full commercial manufacturing, ensuring robust quality assurance, global regulatory alignment, and secure cross-border supply chain and logistics coordination.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : 3-Hydroxybenzotrifluoride (CAS No: 98-17-9), also known as mHBTF, is undergoing a significant transition from a standard speciality reagent to a vital, high-performance polymer and agrochemical intermediate in the global crop protection and advanced material science markets, where its exceptional fluorinated reactivity and customisable molecular design are leveraged across diverse megaproject and bulk synthesis applications. Serving as a fundamental trifluoromethylated aromatic core, 3-Hydroxybenzotrifluoride is a cornerstone of the international organic synthesis supply chain, supporting the global manufacturing of high-potency selective herbicides like Diflufenican, technical-grade fungicides, and critical pharmaceutical building blocks. Beyond standard chemical intermediate roles, its robust chemical profile makes it highly valuable in cross-border pharmaceuticals and fine chemical synthesis, functioning as a critical building block for modern life-saving antiviral therapeutics like Sofosbuvir, a high-efficiency synthesis reactant for 2-[3-(Trifluoromethyl)phenoxy]nicotinic acid, and a specialized industrial intermediate. This versatility reflects a global sourcing shift toward validated, high-purity liquid variants to guarantee predictable reaction kinetics and consistent material performance worldwide. As a globally established 3-Hydroxybenzotrifluoride supplier, we ensure dependable bulk supply, strict quality control, and complete technical dossiers, including 3-Hydroxybenzotrifluoride CoA and TDS across all industrial and technical grades. Beyond supply, we support our international partners through the entire product lifecycle from pilot-scale chemical optimisation to full commercial manufacturing, ensuring robust quality assurance, global regulatory alignment, and secure cross-border supply chain and logistics coordination.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Faropenem sodium (CAS 106560-14-9) is experiencing a strategic resurgence in the global anti-infective segment as a critical oral carbapenem, bridging the therapeutic gap between traditional beta-lactams and parenteral carbapenem therapy for multidrug-resistant respiratory and urinary tract infections. Market intelligence indicates that the adoption of high-purity faropenem is being propelled by the clinical shift toward oral switch therapies in outpatient parenteral antimicrobial therapy (OPAT) models, particularly across the Asia-Pacific region where the burden of ESBL-producing pathogens remains high. The increasing focus on paediatric and geriatric-friendly formulations has also catalysed R&D investments into advanced granulations and taste-masking technologies, further solidifying its position as a preferred broad-spectrum agent in both hospital-acquired and community-acquired infection protocols. We are an established Faropenem API supplier with >= 99% purity globally for semi-finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Faropenem COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Apremilast (CAS No: 608141-41-9) represents a pivotal advancement in the global speciality chemicals and biopharmaceutical sectors as a small-molecule phosphodiesterase 4 (PDE4) inhibitor, currently valued at approximately USD 2.67 billion with a projected growth to USD 3.95 billion by 2032. The market is increasingly driven by the robust demand for targeted oral immunomodulatory therapies, particularly for chronic inflammatory conditions such as moderate to severe plaque psoriasis and psoriatic arthritis, where the 30 mg dosage strength remains the dominant therapeutic standard. Technical advancements in the synthesis of this crystalline active substance focus on optimising the six-step reaction process to manage its inherent chirality and polymorphism, specifically ensuring the consistent production of the stable polymorphic B form to meet stringent international pharmacopoeial and regulatory standards. Furthermore, the strategic shift towards the Asia-Pacific region, coupled with the expansion of label indications and the entry of high-quality generic alternatives, is reshaping the competitive landscape for CDMOs and API manufacturers who prioritise enantiomeric purity and rigorous analytical validation via HPLC, NMR, and XRD techniques. We are an established Apremilast api supplier with >= 99% purity globally for semi-finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Apremilast COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : 3-Bromo-8-methylimidazo[1,2-a]pyridine-6-carboxylic acid (C₉H₇BrN₂O₂) is a highly functionalised, bicyclic heterocyclic building block extensively utilised as an advanced intermediate in discovery-phase medicinal chemistry, high-throughput screening campaigns, and commercial API synthesis. Due to its rigid, electron-rich core and orthogonal halogen/carboxylic acid handle configuration-serves-critical candidate framework across multiple innovative drug development sectors Synthetic viability and downstream efficiency of our 3-Bromo-8-methylimidazo[1,2-a]pyridine-6-carboxylic acid rely on rigorous regioselective control during ring closure and subsequent halogenation. Imidazo[1,2-alpyridine nucleus naturally features competitive nucleophilic and electrophilic reaction centres. If the electronic properties of the starting aminopyridine or alpha-halocarbonyl precursors are unevenly managed, side reactions like self-condensation, decarboxylation, or multi-halogenation can occur. These impurities are highly structural mimics that easily carry forward, permanently poisoning precious organometallic catalysts during late-stage cross-coupling phases. Our advanced processing infrastructure eliminates open-market structural variance through strict control of reaction parameters. Our multi-step synthesis path utilises ultra-pure aminopyridine starting materials paired with stabilised acetal keys to guarantee a completely regioselective cyclisation loop. Final electrophilic bromination is tamely managed using electronic stabilisation additives to enforce highly targeted monobromination at the C-3 position while leaving the aromatic methyl group untouched. The resulting product is processed through a targeted chemical wash to remove raw succinimide complexes, delivering an exceptionally pure crystalline intermediate with an ultra-low trace-ash baseline. This level of purity ensures predictable, high-yield results for discovery chemists and scale-up engineers alike. We are a premier 3-Bromo-8-methylimidazo[1,2-a]pyridine-6-carboxylic acid supplier for high-purity 3-Bromo-8-methylimidazo[1,2-a]pyridine-6-carboxylic acid, ensuring consistent melting points and precise assay values. We deliver a comprehensive selection of 3-Bromo-8-methylimidazo[1,2-a]pyridine-6-carboxylic acid grades with full analytical documentation, including batch-specific (HPLC) purity verification profiles and supporting quality assurance data 3-Bromo-8-methylimidazo|1,2-aJpyridine-6-carboxylic acid COA and TDS. We ensure secure supply chains from pilot-lot evaluations to multi-container commercial campaigns worldwide with reliable lead time and global supply capabilities and logistics coordination in over 17+ countries.
Category : Excipients
Sub-Category : Solvents & Solubilizers
Description : Our N,N-Dimethylacetamide (DMAc) is a premium, high-purity polar aprotic industrial solvent engineered for high-performance polymer processing and advanced pharmaceutical synthesis, now available for bulk wholesale purchase at competitive contract pricing. Structurally classified as a heavy-duty aliphatic amide registered under CAS Number 127-19-5, it delivers an exceptionally high dipole moment with highly sought-after chemical stability and high-boiling solvency power. While downstream product formulators often confuse it with standard universal solvents or generic dimethylformamide substitutes, our high-purity DMAc functions as an intricate reaction medium and polymer solubiliser rather than a flat, single-dimension carrier fluid. Our product achieves this distinctive profile through precision chemical synthesis and rigorous fractional distillation that ensures a consistent ultra-pure assay and absolute clarity in liquid matrices. This microstructural balance of CH₃CON(CH₃)₂ provides a robust vapour pressure profile with an optimised volatility rate, functioning as a structural anchor that provides exceptional thermal resistance with an outstanding boiling point exceeding 165°C. As an established global Dimethylacetamide supplier offering direct-from-factory sourcing, we ensure a dependable supply chain, consistent refractive index standardisation, tiered container-load bulk discounts, complete regulatory documentation (including CoA, SDS, & REACH certification), and seamless global logistics coordination for international B2B delivery.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : tert-Butyldimethylsilane (CAS No: 29681-57-0) serves as a critical silicon-based reagent in the high-growth CDMO and specialty chemical sectors, where its role as a sterically hindered protecting group is paramount for shielding reactive functional groups during the complex, multi-step synthesis of novel therapeutic agents. Beyond its established utility in medicinal chemistry, this versatile organosilicon compound is increasingly being integrated into the production of advanced silicone polymers and high-performance coatings, where it significantly enhances thermal stability and mechanical robustness for demanding automotive and microelectronic applications. Furthermore, the rising demand for high-purity TBDMCS is underpinned by its precision application in surface modification and the development of self-assembled monolayers, which are essential for improving material adhesion and hydrophobicity in the next generation of semiconductor sensors and optoelectronic devices. As a globally established tert-Butyldimethylsilane supplier with 95% purity, we ensure dependable supply, consistent quality, and complete regulatory documentation, including tert-Butyldimethylsilane CoA and tert-Butyldimethylsilane TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : Piperazine (CAS No: 110-85-0) is a versatile heterocyclic building block highly valued in the global fine chemicals market, where its unique nitrogen-rich structure serves as a critical intermediate for the custom synthesis of active pharmaceutical ingredients, including anthelmintic, antipsychotic, and antihistamine medications. Beyond pharmaceuticals, piperazine acts as a vital precursor in the agrochemical sector for formulating advanced crop protection agents such as fungicides and herbicides, while simultaneously seeing expanding industrial deployment in polymer curing, carbon capture gas treatment, and water treatment systems. Driven by escalating global healthcare compliance requirements and rising intensive agricultural demands, this organic compound continues to witness robust consumption across diverse specialty chemical sectors. As globally established Piperazine supplier with custom purity grades, we ensure dependable supply, consistent quality, and complete regulatory documentation, including Piperazine CoA and Piperazine TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.
Category : Pre finished formulations
Sub-Category : Pellets
Description : Our high-potency Itraconazole Pellets represent the pinnacle of solid oral dosage drug delivery, specifically engineered to overcome the profound bioavailability barriers inherent to BCS Class II triazole antifungals. Operating as a vertically integrated CDMO partner, we provide systemic, value-added pre-finished formulations optimised for immediate downstream encapsulation and compression. Our architectural value chain control is explicitly structured through four specialised refinement stages: Itraconazole Intermediate IT9, Itraconazole Intermediate IT7, Itraconazole API (ITC), Itraconazole Pellets (Pre-finished Formulation). This advanced material directly addresses the high-intent formulation criteria of international pharmaceutical manufacturers and global therapeutic sourcing. Scimplify's role in the commercial and physical efficiency of Itraconazole Pellets are the direct result of our complete, end-to-end integration across the molecular lifecycle, characterised by extreme lipophilicity and a near-total lack of water solubility, creating severe absorption hurdles in the human gastrointestinal tract. By managing the value chain continuously evolving from KSMs > core intermediates > APIs and all the way to pre-finished formulations, we eliminate the manufacturing inconsistencies that plague open-market sourcing. We are a premier Itraconazole Pellets supplier for high-purity Itraconazole Pellets, ensuring consistent melting points and precise assay values. We deliver a comprehensive selection of Itraconazole Pellets grades with full analytical documentation, including batch-specific dissolution rate verification profiles and supporting quality assurance data Itraconazole Pellets COA. We ensure secure supply chains from pilot-lot evaluations to multi-container commercial campaigns worldwide with reliable lead time and global supply capabilities.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description : Calcium acetate monohydrate (CAS No: 5743-26-0) occupies a critical position in the global speciality chemicals market, primarily driven by its dual-functional role as a high-affinity phosphate binder in pharmaceutical renal care and a versatile stabiliser in the food and beverage industry. In the pharmaceutical sector, the compound is indispensable for managing hyperphosphatemia in patients with end-stage renal disease, where its high solubility and controlled calcium release profiles are superior to traditional carbonate-based binders. Within the food science landscape, it functions as a highly effective antimicrobial and acidity regulator, particularly in the industrial bakery sector to prevent rope formation caused by Bacillus species, while also serving as a secondary calcium fortifier in functional dairy and nutraceutical products. Furthermore, the industrial application of calcium acetate monohydrate is expanding into environmental technologies, specifically in flue-gas desulphurisation and wastewater treatment, where it acts as a precise precipitant for fluoride and heavy metal removal, meeting increasingly stringent global regulatory standards for industrial discharge. As a globally established Calcium acetate monohydrate supplier with high purity levels, we ensure dependable supply, consistent quality, and complete regulatory documentation, including Calcium acetate monohydrate CoA and Calcium acetate monohydrate TDS across all grades. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, and analytical method development to scale-up, process optimisation, and pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.
Ensure globally resilient supply chains
Backed by 10+ patents and decades of experience.
Tailored support for your unique needs.
Delivering to 30+ countries.
2781 products available across our life science range.
Enter your personal data to create your account